Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Revlimid
Pharma
ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma
Both J&J's Darzalex and Sanofi's Sarclisa showed strong efficacy in newly diagnosed myeloma, but only one result is considered practice-changing.
Angus Liu
Dec 12, 2023 12:00pm
Sanofi targets first-line myeloma as Sarclisa delivers trial win
Dec 7, 2023 11:26am
BMS aims for staggering 25 label expansions in the coming years
Sep 15, 2023 12:04pm
BMS again cuts staff after disappointing 2Q earnings
Aug 11, 2023 2:41pm
BMS, BeiGene end legacy Celgene deal years after China ban
Aug 3, 2023 10:25am
With Revlimid sales down, BMS slashes 2023 revenue projection
Jul 27, 2023 11:43am